Spotlight -

B + L Dry Eye Series|

Zeiss Clinical Cases

Viewing

News

retina treatment burden

ST laser therapy may reduce DME intravitreal injections

ByPauline T. Merrill, MD

June 18th 2020

Used as an adjunct, ST laser therapy may reduce the treatment burden for patients while maintaining visual acuity.

New frontier in micropulse laser treatment for retinal disorders

Turning to new frontier in micropulse laser treatment for retinal disorders

ByEmiliano Di Carlo, MD

June 1st 2020

amniotic membrane

Role of human amniotic membrane in surgery of recurrent macular holes

ByEmiliano Di Carlo, MD,Camilla Simini, MD

May 19th 2020

Danny Haddad

COVID-19: How Orbis International is managing operations

ByAlex Delaney-Gesing

May 9th 2020

Real world versus patient trials

How DME patients may fare differently in ‘real world’ versus trials

ByLynda Charters

May 4th 2020

artificial intelligence

Screening DR + tele-ophthalmology AI: Less expensive than human assessment

ByLynda Charters

May 4th 2020

chronic intravitreal injections

Determining risk of ocular damage from chronic intravitreal injections

ByLynda Charters

April 24th 2020

Collagen corneal CXL

PACK-CXL researchers continue to clear hurdles of topical drugs

ByLynda Charters

April 16th 2020

pandemics in the U.S.

Echoes of history: COVID-19 pandemic stirs memories, tests our mettle

ByPeter J. McDonnell, MD

April 15th 2020

Pediatric eye patient

Technology 'perfect' for pediatric neuro-ophthalmology diagnoses

ByLynda Charters

April 13th 2020

Coronavirus

Researchers find low risk of COVID-19 transmission in tears

ByLynda Charters

April 11th 2020

glaucoma

Pharmacologic treatment an option for open-angle glaucoma

ByMichelle Dalton, ELS

April 10th 2020

Andrew Lee

COVID-19: How neuro-ophthalmology is acclimating in the pandemic era

ByAlex Delaney-Gesing

April 10th 2020

generations

Coronavirus response: Generations react differently to COVID-19

ByPeter J. McDonnell, MD

April 9th 2020

Shan Lin

COVID 19: Tips for protecting patients/staff

ByAlex Delaney-Gesing

April 8th 2020

Why timing is everything in AMD

ByAllen C. Ho, MD

April 7th 2020

Arshad Khanani

COVID-19: Putting safety measures into practice

ByAlex Delaney-Gesing

April 3rd 2020

Roberto Pinelli

COVID-19: Impact of pandemic on Switzerland's ophthalmic space

ByAlex Delaney-Gesing

April 2nd 2020

What retinal specialists should know about their pregnant patients

ByLynda Charters

April 1st 2020

Paul Sidoti

COVID-19: Keeping staff and patients safe during a pandemic

ByPaul A. Sidoti, MD

April 1st 2020

How autonomous diagnostics for DR gave a ‘jump-start’ to AI in ophthalmology

ByLynda Charters

March 30th 2020

Carl Awh

COVID-19: Life in the time of coronavirus

ByAlex Delaney-Gesing

March 30th 2020

Rishi Singh, MD

COVID-19: How eyecare professionals are taking precautions

ByRishi P. Singh, MD, FASRS

March 23rd 2020

laser for diabetic macular edema

Subthreshold laser may reduce intravitreal injections for DME

ByPauline T. Merrill, MD

March 3rd 2020

eye injections

IRIS Registry study: Overall anti-VEGF injection intervals for wet AMD similar at 1, 2 years of treatment

ByMathew W. MacCumber, MD, PhD

March 3rd 2020

AMD awareness: Close focus on preserving vision

ByLynda Charters

February 21st 2020

PRN ranibizumab outcomes over the long term in real world

ByMichelle Dalton, ELS

February 20th 2020

Consensus group redefines, standardizes AMD classifications

ByMichelle Dalton, ELS

February 13th 2020

Diagnosing AMD for the non-retina specialist

ByMichelle Dalton, ELS

February 13th 2020

Stem cell therapy

Stem cell transplantation: Restoring vision in AMD may be possible

ByLynda Charters

February 10th 2020